JP2023179414A5 - - Google Patents
Info
- Publication number
- JP2023179414A5 JP2023179414A5 JP2023135227A JP2023135227A JP2023179414A5 JP 2023179414 A5 JP2023179414 A5 JP 2023179414A5 JP 2023135227 A JP2023135227 A JP 2023135227A JP 2023135227 A JP2023135227 A JP 2023135227A JP 2023179414 A5 JP2023179414 A5 JP 2023179414A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- apheresis
- subject
- raav vector
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762533579P | 2017-07-17 | 2017-07-17 | |
| US62/533,579 | 2017-07-17 | ||
| PCT/US2018/042553 WO2019018439A1 (en) | 2017-07-17 | 2018-07-17 | APHERESE METHODS AND ASSOCIATED USES |
| JP2020502112A JP2020530834A (ja) | 2017-07-17 | 2018-07-17 | アフェレーシスの方法及び使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502112A Division JP2020530834A (ja) | 2017-07-17 | 2018-07-17 | アフェレーシスの方法及び使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023179414A JP2023179414A (ja) | 2023-12-19 |
| JP2023179414A5 true JP2023179414A5 (https=) | 2026-02-24 |
Family
ID=65016674
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502112A Pending JP2020530834A (ja) | 2017-07-17 | 2018-07-17 | アフェレーシスの方法及び使用 |
| JP2023135227A Pending JP2023179414A (ja) | 2017-07-17 | 2023-08-23 | アフェレーシスの方法及び使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502112A Pending JP2020530834A (ja) | 2017-07-17 | 2018-07-17 | アフェレーシスの方法及び使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200164008A1 (https=) |
| EP (1) | EP3655001A4 (https=) |
| JP (2) | JP2020530834A (https=) |
| CN (1) | CN111225677A (https=) |
| AU (1) | AU2018304194B2 (https=) |
| BR (1) | BR112020000995A2 (https=) |
| CA (1) | CA3069880A1 (https=) |
| MX (1) | MX2020000713A (https=) |
| WO (1) | WO2019018439A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017096162A1 (en) | 2015-12-02 | 2017-06-08 | Voyager Therapeutics, Inc. | Assays for the detection of aav neutralizing antibodies |
| CN120393053A (zh) | 2018-06-18 | 2025-08-01 | 全国儿童医院研究所 | 用于治疗肌营养不良的肌肉特异性微小肌营养不良蛋白的腺相关病毒载体递送 |
| EP3715374A1 (en) | 2019-03-23 | 2020-09-30 | Ablevia biotech GmbH | Compound for the sequestration of undesirable antibodies in a patient |
| US11986536B2 (en) | 2019-03-23 | 2024-05-21 | Ablevia Biotech Gmbh | Compound for the sequestration of undesirable antibodies in a patient |
| KR20220133969A (ko) | 2020-01-28 | 2022-10-05 | 프리라인 테라퓨틱스 리미티드 | 바이러스 벡터에 대한 중화 항체 역가를 결정하기 위한 개선된 분석법 |
| EP4164668A1 (en) * | 2020-06-15 | 2023-04-19 | Research Institute at Nationwide Children's Hospital | Adeno-associated virus vector delivery for muscular dystrophies |
| CN111500635B (zh) * | 2020-07-02 | 2020-10-09 | 北京大学第三医院（北京大学第三临床医学院） | 一种包含携带核酸分子的载体的试剂盒 |
| RU2020122141A (ru) * | 2020-07-03 | 2022-01-04 | Максим Петрович Никитин | Способ и композиция на основе генотерапевтического агента и антитела, связывающегося с клетками крови |
| JP2023542390A (ja) | 2020-09-23 | 2023-10-06 | アブレヴィア バイオテック ゲーエムベーハー | ウイルスベクターの有効性を増強するための化合物 |
| JP2023548746A (ja) | 2020-10-13 | 2023-11-21 | クリヤ セラピューティクス インコーポレイテッド | サイトカインをコードする核酸を送達するためのウイルスベクターコンストラクトおよびがんを処置するためのその使用 |
| WO2023064382A1 (en) * | 2021-10-16 | 2023-04-20 | Isaac Eliaz | Apheresis of whole blood |
| AU2023238299A1 (en) | 2022-03-24 | 2024-11-07 | Ablevia Biotech Gmbh | Compound for increasing efficacy of oncolytic viruses |
| WO2026028158A1 (en) * | 2024-07-31 | 2026-02-05 | Biohaven Therapeutics Ltd. | Targeted degradation of anti-aav antibodies to enable aav-based gene therapy |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2242189T3 (es) * | 1994-05-13 | 2005-11-01 | Miltenyi Biotec Gmbh | Columna esteril y apirogena copulada a una proteina con miras a la fijacion y extraccion de sustancias dadas de la sangre. |
| US6406861B1 (en) * | 1998-10-07 | 2002-06-18 | Cell Genesys, Inc. | Methods of enhancing effectiveness of therapeutic viral immunogenic agent administration |
| AU4860600A (en) * | 1999-06-03 | 2000-12-28 | Advanced Extravascular Systems | One step removal of unwanted molecules from circulating blood |
| US6464976B1 (en) * | 1999-09-07 | 2002-10-15 | Canji, Inc. | Methods and compositions for reducing immune response |
| US6379708B1 (en) * | 1999-11-20 | 2002-04-30 | Cytologic, Llc | Method for enhancing immune responses in mammals |
| AT500483B1 (de) * | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| JP2010131033A (ja) * | 2007-03-16 | 2010-06-17 | Medical Science Co Ltd | 医療用吸着剤 |
| US8123713B2 (en) * | 2008-08-12 | 2012-02-28 | Caridian Bct, Inc. | System and method for collecting plasma protein fractions from separated blood components |
| WO2011117258A2 (en) * | 2010-03-22 | 2011-09-29 | Association Institut De Myologie | Methods of increasing efficiency of vector penetration of target tissue |
| US20130068691A1 (en) * | 2011-08-05 | 2013-03-21 | Henry John Smith | Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders |
| ES2857773T5 (es) * | 2011-08-24 | 2024-06-04 | Univ Leland Stanford Junior | Nuevas proteínas de la cápside de AAV para la transferencia de ácidos nucleicos |
| SE1200356A1 (sv) * | 2011-10-30 | 2013-05-01 | Kurt Nilsson | Polymerbaserad produkt och användning |
| US9434928B2 (en) * | 2011-11-23 | 2016-09-06 | Nationwide Children's Hospital, Inc. | Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides |
| AU2013221212B2 (en) * | 2012-02-17 | 2018-08-09 | The Children's Hospital Of Philadelphia | AAV vector compositions and methods for gene transfer to cells, organs and tissues |
| US9717841B2 (en) * | 2012-09-11 | 2017-08-01 | Gary L. McNeil | Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source |
| KR20240090694A (ko) * | 2013-07-22 | 2024-06-21 | 더 칠드런스 호스피탈 오브 필라델피아 | 변종 ａａｖ 및 조성물, 세포, 기관 및 조직으로의 유전자 전이를 위한 방법 및 용도 |
| CN107002096A (zh) * | 2014-10-06 | 2017-08-01 | 阿罗根有限公司 | 基于aav的基因疗法 |
| EP3054007A1 (en) * | 2015-02-09 | 2016-08-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step |
| US20180093032A1 (en) * | 2016-08-15 | 2018-04-05 | Henry John Smith | Targeted apheresis using binding agents or ligands immobilized on membranes |
| WO2018045347A1 (en) * | 2016-09-02 | 2018-03-08 | Spark Therapeutics, Inc. | Methods and vectors for treating cns disorders |
| WO2018109207A1 (en) * | 2016-12-16 | 2018-06-21 | Uniqure Ip B.V. | Immunoadsorption |
| WO2018158397A1 (en) * | 2017-03-02 | 2018-09-07 | Genethon | Method for removing anti-aav antibodies from a blood-derived composition |
| MX2020004830A (es) * | 2017-11-08 | 2020-11-11 | Avexis Inc | Medios y metodo para preparar vectores virales y usos de los mismos. |
-
2018
- 2018-07-17 MX MX2020000713A patent/MX2020000713A/es unknown
- 2018-07-17 CN CN201880060309.6A patent/CN111225677A/zh active Pending
- 2018-07-17 US US16/631,692 patent/US20200164008A1/en active Pending
- 2018-07-17 AU AU2018304194A patent/AU2018304194B2/en active Active
- 2018-07-17 CA CA3069880A patent/CA3069880A1/en active Pending
- 2018-07-17 JP JP2020502112A patent/JP2020530834A/ja active Pending
- 2018-07-17 EP EP18835932.7A patent/EP3655001A4/en active Pending
- 2018-07-17 BR BR112020000995-4A patent/BR112020000995A2/pt unknown
- 2018-07-17 WO PCT/US2018/042553 patent/WO2019018439A1/en not_active Ceased
-
2023
- 2023-08-23 JP JP2023135227A patent/JP2023179414A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023179414A5 (https=) | ||
| Konno et al. | Efficient whole brain transduction by systemic infusion of minimally purified AAV-PHP. eB | |
| Liu et al. | Crossing the blood-brain barrier with AAV vectors | |
| AU2023200175B2 (en) | Recombinant Adeno-Associated Virus Delivery Of Exon 2-Targeted U7snRNA Polynucleotide Constructs | |
| JP6991095B2 (ja) | ウイルスベクター精製における拡張可能な製造プラットフォームおよび遺伝子治療における使用のための高純度ウイルスベクター | |
| Daya et al. | Gene therapy using adeno-associated virus vectors | |
| JP2020533959A5 (https=) | ||
| EP3039146B1 (en) | Products and methods for treatment of amyotrophic lateral sclerosis | |
| AU2018304194B2 (en) | Apheresis methods and uses | |
| AU2023217698A1 (en) | Aav capsid variants and uses thereof | |
| CA3061365A1 (en) | Modulatory polynucleotides | |
| GB2574243A (en) | Adeno-associated viral vector-mediated gene therapy for treating fragile X-associated disorders | |
| KR20210148273A (ko) | 근육 발현을 위한 하이브리드 프로모터 | |
| CA3259902A1 (en) | AAV Capsid Variants and Their Uses | |
| US20250388626A1 (en) | Aav capsid variants and uses thereof | |
| WO2025038430A1 (en) | Aav capsid variants and uses thereof | |
| Benchaouir et al. | Gene and splicing therapies for neuromuscular diseases | |
| Sorroza-Martinez et al. | Recent Advances in Therapeutics and Manufacturing Processes of Recombinant Adeno-Associated Virus for the Treatment of Lung Diseases | |
| Morgenstern et al. | Adeno-associated viral gene delivery in neurodegenerative disease | |
| JPWO2021081236A5 (https=) | ||
| Henriques et al. | Isolation of biologically active extracellular vesicles-associated AAVs for gene delivery to the brain by size exclusion chromatography | |
| de Almeida et al. | Isolation of Biologically Active Extracellular Vesicles-Associated AAVs for Gene Delivery to the Brain by Size Exclusion Chromatography | |
| HK40098369A (en) | Products and methods for treatment of amyotrophic lateral sclerosis | |
| AU2023306319A1 (en) | Adeno-associated virus gene therapy products and methods | |
| Van der Perren et al. | Using recombinant adeno-associated viral vectors for gene expression in the brain |